DDevicare
Devicare is a Barcelona-based (Sant Cugat del Vallès) specialty biotech/digital-health company focused exclusively on urology, combining nutritional therapy science with connected medical devices and apps. Its flagship product, Lit-Control, is a Bluetooth-connected pH meter paired with a mobile app to prevent kidney stone recurrence; the company raised a $3M Series A in 2021 and in February 2026 acquired US supplement maker IP6 International to enter the American market.
SectorsHealthtech, Biotech, Digital Therapeutics, Urology, Medical Devices
Start-up MapHealthtech & Bio › Medical devices & surgical hardware
Founders
Global models 4
HHealthy.io
Israel · healthy.io ↗
Makes smartphone-connected at-home urine tests and apps for kidney and urology conditions, sold to health systems and payers.
$150MComparable
WWithings
France · www.withings.com ↗
Sells connected consumer health devices, including the U-Scan at-home urine analyser that tracks urine pH and nutrition markers through an app.
$100MComparable
SScanwell Health
United States · www.scanwellhealth.com ↗
Sells smartphone-read at-home urine tests with an app, for monitoring urinary tract and kidney conditions.
$15MComparable
VVivoo
Turkey · vivoo.io ↗
Pairs at-home urine test strips, including pH, with an app that gives personalised nutrition advice and supplement recommendations.
$8MComparable
In the same niche 72 others
See all in the Start-ups Map →
AAnaconda Biomed
Sant Cugat del Vallès
Series C (estimated) · €90.1M
IINBRAIN Neuroelectronics
Barcelona
Series B (estimated) · €84.5M
OOverture Life
Madrid
Venture Debt · €71.2M
M
Medlumics
Madrid
No stage disclosed · €57.8M
AAortyx
Barcelona
Series A · €16.9M
NNuubo
Madrid
Series B (estimated) · €16.3M
Notes: Most funded first
Investors 11
Open as list →
CCapital Cell
capitalcell.com
SShip2B Ventures
www.ship2b.org
S
Successful Capital
successful.fund
EEuropean Investment Fund
www.eif.org
E
EMESA Corporación Empresarial
A
Advanced MedTech Holdings
J
Juan Knuth
G
Gaya family (Eladiet)
S
Serra family (Boyser)
X
Xiol family (Peroxfarma)
EEmesa Capital
Funding rounds 4
·2 not counted| Date | Round | Amount | Lead |
|---|---|---|---|
| 2021-01-07 | Series A | $3M |
Advanced MedTech Holdings
+4 more
|
| 2020-03-13 | Seed (estimated) | — |
Lead not disclosed
+1 more
|
| 2019-07-02 | Seed (estimated) | approximately €1.6M |
Lead not disclosed
+1 more
|
| 2017-05-05 | Seed | €3M |
EMESA Corporación Empresarial
+4 more
|
Not counted (2)
| 2019-07-02 | Public Loan | €500K | Avançsa |
| 2017-05-05 | Public Loan | €270K | ENISA |
News
No coverage on record yet.